Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation.

Literature DB >> 21694799

Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation.

Michael Camilleri¹.

Abstract

Entities: Disease

Year: 2011 PMID： 21694799 PMCID： PMC3105610 DOI： 10.1177/1756283X11401773

Source DB: PubMed Journal: Therap Adv Gastroenterol ISSN： 1756-283X Impact factor: 4.409

× No keyword cloud information.

22 in total

1. Relationships between pelvic floor symptoms and function in irritable bowel syndrome.

Authors: G Prott; L Shim; R Hansen; J Kellow; A Malcolm
Journal: Neurogastroenterol Motil Date: 2010-05-06 Impact factor: 3.598

Review 2. Chronic constipation.

Authors: Anthony Lembo; Michael Camilleri
Journal: N Engl J Med Date: 2003-10-02 Impact factor: 91.245

3. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Authors: E P Bouras; M Camilleri; D D Burton; G Thomforde; S McKinzie; A R Zinsmeister
Journal: Gastroenterology Date: 2001-02 Impact factor: 22.682

4. Digital rectal examination is a useful tool for identifying patients with dyssynergia.

Authors: Kasaya Tantiphlachiva; Priyanka Rao; Ashok Attaluri; Satish S C Rao
Journal: Clin Gastroenterol Hepatol Date: 2010-07-23 Impact factor: 11.382

5. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.

Authors: Filippo Cremonini; Michael Camilleri; Sanna McKinzie; Paula Carlson; Christopher E Camilleri; Duane Burton; George Thomforde; Raul Urrutia; Alan R Zinsmeister
Journal: Am J Gastroenterol Date: 2005-03 Impact factor: 10.864

5. Diagnosis of functional constipation: agreement between Rome III and Rome II criteria and evaluation for the practicality.

Authors: Hai Wei Xin; Xiu Cai Fang; Li Ming Zhu; Tao Xu; Gui Jun Fei; Zhi Feng Wang; Min Chang; Li Ying Wang; Xiao Hong Sun; Mei Yun Ke
Journal: J Dig Dis Date: 2014-06 Impact factor: 2.325

5 in total

Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation.

1. Relationships between pelvic floor symptoms and function in irritable bowel syndrome.

Review 2. Chronic constipation.

3. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

4. Digital rectal examination is a useful tool for identifying patients with dyssynergia.

5. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.

6. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia.

7. Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life.

8. Constipation in an elderly community: a study of prevalence and potential risk factors.

9. Audit of constipation in a tertiary referral gastroenterology practice.

10. Efficacy of linaclotide for patients with chronic constipation.

1. Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation.

Review 2. Brain-gut axis: from basic understanding to treatment of IBS and related disorders.

3. The impact of laxative use upon symptoms in patients with proven slow transit constipation.

4. Constipation Risk in Patients Undergoing Abdominal Surgery.

5. Diagnosis of functional constipation: agreement between Rome III and Rome II criteria and evaluation for the practicality.